Nisha Rathode (Editor)

Moshe Szyf

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Name  Moshe Szyf

Moshe Szyf httpswwwmcgillcapharmafilespharmaimagesm
Books  DNA Methylation and Cancer Therapy. Medical Intelligence Unit.
Fields  Epigenetics, Cancer research

Rsa nspcc event how nurture alters nature moshe szyf

Moshe Szyf is a geneticist and James McGill professor of pharmacology and therapeutics at the McGill University, where he also holds a GlaxoSmithKline-CIHR chair in pharmacology.


Szyf's main research interests lie with epigenetics, including behavioral epigenetics as well as cancer research.

Moshe szyf behavioral epigenetics

Education and career

Szyf received his Ph.D. from the Hebrew University on basic mechanisms of DNA methylation under supervision of Aharon Razin. Subsequently, he performed postdoctoral work at Harvard Medical School. In 1989, he was appointed as assistant professor in pharmacology and therapeutics at McGill University. In 2016, Moshe Szyf founded Montreal EpiTerapia Inc.


  • Moshe Szyf, DNA Methylation and Cancer Therapy, Springer, 2005, ISBN 978-0306478482
  • Moshe Szyf, Fundamentals of Epigenetics, Cambridge University Press, ISBN 978-0521898379
  • Articles

    As of October 2013, Moshe Szyf published more than 140 papers in peer-reviewed journals, almost all on epigenetics. He is also on the Editorial Board of the journal Environmental Epigenetics, published by Oxford University Press.

    Szyf also holds many patents, all relating to epigenetics-based therapeutics.


    Moshe Szyf Wikipedia

    Similar Topics
    The Bird Store
    Sandra Magsamen
    Dick Enright